Effects of escitalopram on ethanol withdrawal syndrome in rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 6, 2006, Pages 1027-1032

  Saǧlam, Esra ^a   Kayir, Hakan ^b   Çelik, Turgay ^b   Uzbay, Tayfun ^b  

^a MALTEPE UNIVERSITY   (Turkey)

^b Faculty of Medicine   (Turkey)

Author keywords

Escitalopram; Ethanol dependence; Ethanol withdrawal syndrome; Rat(s); Selective serotonin reuptake inhibitors (SSRIs)

Indexed keywords

ALCOHOL; ESCITALOPRAM; SEROTONIN UPTAKE INHIBITOR; SODIUM CHLORIDE;

AGITATION; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; AUDIOGENIC SEIZURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HYPERACTIVITY; LOCOMOTION; MALE; NONHUMAN; RAT; TREMOR; WET DOG SHAKES;

ALCOHOL DRINKING; ANIMALS; ANTIDEPRESSIVE AGENTS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CITALOPRAM; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; MALE; MOTOR ACTIVITY; PSYCHOMOTOR AGITATION; RATS; RATS, WISTAR; SEIZURES; STEREOTYPED BEHAVIOR; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 33745257055     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.03.028     Document Type: Article

References (41)

1. Adams M.L., Sewing B.N., Chen J., Meyer E.R., and Cicero T.J. Nitric oxide related agents alter alcohol withdrawal in male rats. Alcohol Clin Exp Res 19 (1995) 195-199
2. Auquier P., Robitail S., Llorca P.M., and Rive B. Comparison of escitalopram and citalopram efficacy: a meta-analysis. Int J Psychiatry Clin Pract 7 (2003) 259-268
3. Cremers T.I., and Westerink B.H. Pharmacological difference between escitalopram and citalopram. Int J Psychiatry Clin Pract 7 (2003) 306
4. De Witte P., Pinto E., Ansseau M., and Verbanck P. Alcohol withdrawal: from animal research to clinical issues. Neurosci Biobehav Rev 27 (2003) 189-197
5. Ergün H., Uzbay I.T., Çelik T., Kayi{dotless}r H., Yeşilyurt Ö., and Tulunay F.C. Dipyrone inhibits ethanol withdrawal and pentylentetrazole-induced seizures in rats. Drug Dev Res 53 (2001) 254-259
6. Frye G.D., McCown T.J., and Breese G.R. Differential sensitivity of ethanol withdrawal signs in the rat to gamma-aminobutyric acid (GABA) mimetics: blockade of audiogenic seizures but not forelimb tremors. J Pharmacol Exp Ther 226 (1983) 720-725
7. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 14 (1991) 60-67
8. Garthwaite J., Garthwaite G., Palmer R.M., and Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol 172 (1989) 413-416
9. Heinz A., Ragan P., Jones D.W., Hommer D., Williams W., Knable M.B., et al. Reduced central serotonin transporters in alcoholism. Am J Psychiatry 155 (1998) 1544-1549
10. Krystal J.H., Petrakis I.L., Mason G., Trevisan L., and D'Souza D.C. N-methyl-d-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability. Pharmacol Ther 99 (2003) 79-94
11. Lallemand F., and De Witte P. L-NNA decreases cortical vascularization, alcohol preference and withdrawal in alcoholic rats. Pharmacol Biochem Behav 58 (1997) 753-761
12. Lepola U.M., Loft H., and Reines E.H. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 18 (2003) 211-217
13. Lucki I., and Brown K. Different roles of the enantiomers of citalopram on serotonin transmission. Biol Psychiatry 53 (2003) 45S
14. Luo L., and Tan R.-X. Fluoxetine inhibits dendrite atrophy of hippocampal neurons by decreasing nitric oxide synthase expression in rat depression model. Acta Pharmacol Sin 22 (2001) 865-870
15. Majchrowicz E. Induction of physical dependence upon ethanol and the associated behavioral changes in rats. Psychopharmacologia 43 (1975) 1993-1996
16. Miguel-Hidalgo J., and Rajkowska G. Comparison of prefrontal cell pathology between depression and alcohol dependence. J Psychiat Res 37 (2003) 411-420
17. Miller N.S. Pharmacotherapy in alcoholism. J Addict Dis 14 (1995) 23-46
18. Morrisett R.A., Rezvani A.H., Overstreet D., Janowsky D.S., Wilson W.A., and Swartzwelder H.S. MK-801 potently inhibits alcohol withdrawal seizures in rats. Eur J Pharmacol 176 (1990) 103-105
19. Myrick H., Brady K.T., and Malcolm R. New developments in the pharmacotherapy of alcohol dependence. Am J Addict 10 (2001) 3-15 [Suppl.]
20. 3H]citalopram binding to the 5-HT transporter from brain and platelets. Eur J Pharmacol 206 (1991) 243-250
21. Rossetti Z., and Carboni S. Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur J Pharmacol 283 (1995) 177-183
22. Saǧlam E., Uzbay I.T., Kayir H., Çelik T., and Beyazyürek M. Effects of venlafaxine on ethanol withdrawal syndrome in rats. Fundam Clin Pharmacol 18 (2004) 693-698
23. Sánchez C., Bogeso K.P., Ebert B., Reines E.H., and Braestrup C. Escitalopram versus citalopram: the surprising role of the R-enantiomer. Psychopharmacology 174 (2004) 163-176
24. Tabakoff B., Hofmann P., and Moses F. Neurochemical correlates of ethanol withdrawal: alterations in serotoninergic function. J Pharm Pharmacol 29 (1977) 471-476
25. Tatsumi M., Groshan K., Blakely R.D., and Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340 (1997) 249-258
26. Uzbay I.T. L-NAME precipitates catatonia during ethanol withdrawal in rats. Behav Brain Res 119 (2001) 71-76
27. Uzbay I.T., and Erden B.F. Attenuation of ethanol withdrawal signs by high doses of l-arginine in rats. Alcohol Alcohol 38 (2003) 213-218
28. Uzbay I.T., and Kayaalp S.O. A modified liquid diet of chronic ethanol administration: validation by ethanol withdrawal syndrome in rats. Pharmacol Res 31 (1995) 37-42
29. Uzbay I.T., Akarsu E.S., and Kayaalp S.O. Effects of bromocriptine and haloperidol on ethanol withdrawal syndrome in rats. Pharmacol Biochem Behav 49 (1994) 969-974
30. Uzbay I.T., Sever B., Çelik T., and Ayhan I.H. Investigation of the effects of moclobemide in chronic ethanol feeding rats. Pharmacol Res 32 (1995) 287-292
31. Uzbay I.T., Akarsu E.S., and Kayaalp S.O. Effects of flumazenil (Ro 15-1788) on ethanol withdrawal syndrome in rats. Arzneim Forsch-Drug Res 45 (1995) 120-124
32. Uzbay I.T., Erden B.F., Tapanyiǧit E.E., and Kayaalp S.O. Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats. Life Sci 61 (1997) 2197-2209
33. Uzbay I.T., Usanmaz S.E., Tapanyiǧit E.E., Aynaci{dotless}oǧlu Ş., and Akarsu E.S. Dopaminergic and serotonergic alterations in the rat brain during ethanol withdrawal: association with behavioral signs. Drug Alcohol Depend 53 (1998) 39-47
34. Uzbay I.T., Usanmaz S.E., and Akarsu E.S. Effects of chronic ethanol administration on serotonin metabolism in the various regions of the rat brain. Neurochem Res 25 (2000) 257-262
35. Uzbay I.T., Yeşilyurt Ö., Çelik T., Ergün H., and Işi{dotless}mer A. Effects of agmatine on ethanol withdrawal in rats. Behav Brain Res 107 (2000) 153-159
36. Uzbay I.T., Saǧlam E., Kayir H., Çelik T., and Beyazyürek M. Effects of fluoxetine on ethanol withdrawal syndrome in rats. J Psychiat Res 38 (2004) 445-450
37. Uzbay I.T., Çelik T., Aydi{dotless}n A., Kayi{dotless}r H., Tokgöz S., and Bilgi C. Effects of chronic ethanol administration and ethanol withdrawal on cyclic guanosine 3′,5′-monophosphate (cGMP) levels in the rat brain. Drug Alcohol Depend 74 (2004) 55-59
38. Wegener G., Volke V., Harvey B.H., and Rosenberg R. Local, but not systemic administration of serotonergic antidepressant decreases hippocampal nitric oxide synthase activity. Brain Res 959 (2003) 128-134
39. Weissman M.M., and Myers J.K. Clinical depression in alcoholism. Am J Psychiatry 137 (1980) 372-373
40. White F.J. Cocaine and the serotonin saga. Nature 393 (1998) 118-119
41. Yaron I., Shirazi I., Judovich R., Levartovsky D., Caspi D., and Yaron M. Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyalunoric acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum 42 (1999) 2561-2568